Table 2.
Impact of aging and senescence on clinical parameters
Item | Effect | Reference |
---|---|---|
Blood and Bone Marrow | ||
Acid base balance | ↓ | 92 |
Blood Lipidome | ↓↑ | 93-94 |
Blood Metabolome | ↓↑ | 95-96 |
Blood pressure | ↑ | 97 |
Bone marrow function | ↓ | 98-100 |
Integrity of endothelial barriers | ↓ | 16-17 |
Bone | ||
Bone mass | ↓ | 101 |
ECM | ||
ECM biosynthesis and organization | ↓ | 102-103 |
ECM degradation | ↑ | 104 |
Energy and Metabolism | ||
Glucose tolerance | ↓ | 105-106 |
Energy utilization - Appetite and stamina | ↓ | 107-110 |
Fat depots | ↓ | 111 |
GI tract | ||
Integrity of GI barrier (leaky gut) | ↑ | 16-17 |
Immune Response | ||
Immune response (immunosenescence) | ↓ | 16-17, 112 |
Inflammation | ↑ | 113-116 |
Liver | ||
Liver metabolism | ↓ | 117-118 |
Musculoskeletal System | ||
Muscle mass and physical frailty | ↓ | 119 |
Nervous System | ||
Memory | ↑ | 120 |
Neural plasticity | ↓ | 121 |
Integrity of BBB | ↓ | 122 |
Cognition | ↓ | 110, 122 |
Sleep | ↓ | 124 |
Thermoregulation | ↓ | 107, 125, 126 |
Reproductive System | ||
Fertility | ↓ | 127, 128 |
Respiratory System | ||
Integrity of respiratory tract barrier | ↓ | 16-17 |
Oxygenation | ↓ | 107, 130-131 |
Skin | ||
Integrity of Skin Barrier | ↓ | 16-17 |
Stem Cells and Tissue Regeneration | ||
Stem cell function | ↓ | 16-17, 132-134 |
Tissue regeneration | ↓ | 132, 135, 136 |
Organ Protection | ||
Organ, tissue, and metabolic protection | ↓ | 16-17, 110 |
Senescence | ||
Senescence | ↑ | 115, 137 |
Aging | ||
DNAm Age | ↑ | 44 |
Age-related disorders and disease | ↑ | 88, 110 |
Cancer | ||
Risk of cancer | ↑ | 81, 138 |
Health-span and Lifespan | ||
Health-span | ↓ | 139 |
Lifespan | ↓ | 139, 140 |
↑ Improved or protected, ↓ Deteriorated or reversed, Mutations or other changes that are unlikely to be reversible are not included.